HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection.

Abstract
Leishmaniasis, resulting from infection with the protozoan parasite Leishmania, consists of a wide spectrum of clinical manifestations, from healing cutaneous lesions to fatal visceral infections. A particularly severe form of cutaneous leishmaniasis, termed mucosal leishmaniasis, exhibits decreased IL-10 levels and an exaggerated inflammatory response that perpetuates the disease. Using a mouse model of leishmaniasis, we investigated what cytokines contribute to increased pathology when IL-10-mediated regulation is absent. Leishmania major infected C57BL/6 mice lacking IL-10 regulation developed larger lesions than controls, but fewer parasites. Both IFN-γ and IL-17 levels were substantially elevated in mice lacking the capacity to respond to IL-10. IFN-γ promoted an increased infiltration of monocytes, while IL-17 contributed to an increase in neutrophils. Surprisingly, however, we found that IFN-γ did not contribute to increased pathology, but instead regulated the IL-17 response. Thus, blocking IFN-γ led to a significant increase in IL-17, neutrophils and disease. Similarly, the production of IL-17 by cells from leishmaniasis patients was also regulated by IL-10 and IFN-γ. Additional studies found that the IL-1 receptor was required for both the IL-17 response and increased pathology. Therefore, we propose that regulating IL-17, possibly by downregulating IL-1β, may be a useful approach for controlling immunopathology in leishmaniasis.
AuthorsClaudia Gonzalez-Lombana, Ciara Gimblet, Olivia Bacellar, Walker W Oliveira, Sara Passos, Lucas P Carvalho, Michael Goldschmidt, Edgar M Carvalho, Phillip Scott
JournalPLoS pathogens (PLoS Pathog) Vol. 9 Issue 3 Pg. e1003243 (Mar 2013) ISSN: 1553-7374 [Electronic] United States
PMID23555256 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Interleukin-17
  • Interleukin-1beta
  • Interleukin-10
  • Interferon-gamma
Topics
  • Animals
  • Disease Models, Animal
  • Down-Regulation
  • Female
  • Humans
  • Interferon-gamma (blood, immunology)
  • Interleukin-10 (deficiency, genetics)
  • Interleukin-17 (blood, immunology)
  • Interleukin-1beta (metabolism)
  • Leishmania major (pathogenicity, physiology)
  • Leishmaniasis, Cutaneous (immunology, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monocytes (immunology)
  • Neutrophil Infiltration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: